Sun Pharma Advanced Research Company (SPARC) has surged nearly 12% at Rs 162, in otherwise subdued market, on back of heavy volumes on the bourses. The stock opened at Rs 144 on BSE and has seen over four-fold jump in trading volumes.
A combined 3.07 million shares representing 4% free-float equity of the company have changed hands on the counter till 1115 hours against an average less than 400,000 shares that were traded daily in past two weeks on BSE and NSE.
Since October 29, shares of SPARC, a pharma research and drug discovery company, has rallied 26% after the company said it has reported a net loss of Rs 7.65 crore for the second quarter ended September 30, 2013 against net loss of Rs 24.12 crore in the corresponding period previous fiscal. The benchmark S&P BSE Sensex has declined 1.94% during the same period.
Income from operations of the company also rose to Rs 25.84 crore for the quarter under consideration from Rs 4.85 crore for the same period year ago, it added.
A combined 3.07 million shares representing 4% free-float equity of the company have changed hands on the counter till 1115 hours against an average less than 400,000 shares that were traded daily in past two weeks on BSE and NSE.
Since October 29, shares of SPARC, a pharma research and drug discovery company, has rallied 26% after the company said it has reported a net loss of Rs 7.65 crore for the second quarter ended September 30, 2013 against net loss of Rs 24.12 crore in the corresponding period previous fiscal. The benchmark S&P BSE Sensex has declined 1.94% during the same period.
Income from operations of the company also rose to Rs 25.84 crore for the quarter under consideration from Rs 4.85 crore for the same period year ago, it added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%